The company forecasts $5 billion in COVID vaccine ... our list price—when we have our updated vaccines—to be in the range of $110 to $130," Garay said. In March, Moderna CEO Stéphane Bancel ...
The company did not change its forecast of $5 billion in COVID vaccine sales for the year based on advance purchase agreements. But Moderna said it was in discussions about new contracts with ...
Moderna maintained its full-year guidance of a minimum of $5 billion in revenue from its Covid vaccine, which will come from signed government contracts for the shot. CEO Stéphane Bancel said ...
Moderna hits roadblock in flu Moderna CEO defends Covid vaccine price hike in Senate grilling Related: Moderna CEO defends Covid vaccine price hike in Senate grilling ...
The logistics involved will become more costly and complex than when Moderna was selling directly to national governments. But the company plans on increasing the price of its vaccine to as much ...
The CEO of Moderna ... to raise the price of its shot to $130 later this year. Moderna had previously considered raising the commercial price to between $82 and $100 per dose. Covid vaccines ...
Pfizer and Moderna say their work on their blockbuster Covid vaccines is ... length of the mRNA strand in the vaccine, according to Burton. The shot could increase the number of vaccine ...
Moderna has pledged never to enforce ... to share its technology with initiatives aimed at increasing vaccine manufacturing capacity in low- and middle-income countries. “It’s a very big announcement, ...
Moderna (NASDAQ ... Decline 20% In December? Vaccine specialist Novavax (NASDAQ: NVAX) - which is seen as a key player in the Covid-19 vaccine space - saw its stock price decline by about 20% ...
A US biotech is accusing the pair of infringing several of its “foundational” lipid particle patents | Pfizer and BioNTech ...
A vial of the Moderna coronavirus disease (COVID-19) booster vaccine targeting BA.4 and BA.5 Omicron sub variants is pictured at Skippack Pharmacy in Schwenksville, Pennsylvania, U.S., September 8 ...
